Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
Recruiting · NCT06119061 · Registry updated 2025-12-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Recruiting | Phase 4 | 2025-12-26 | NCT06119061 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aaron Cook | 2 |
| Cumberland Pharmaceuticals | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Kentucky | Lexington | United States | 98 |